Issn Print: 0887-6924
Publication Date: 2017/12/25
Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis
A Pardanani; J Gotlib; A W Roberts; M Wadleigh; S Sirhan; J Kawashima; J A Maltzman; L Shao; V Gupta; A Tefferi
Author Information: Division of Hematology, Mayo Clinic, Rochester, MN, USA;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.